What do systematic reviews say?

Intervention not reported

The intervention showed no clear difference in death/progress (instead of event‐free survival)[2] (low certainty).

• Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission 2015 · Cochrane Headline outcomes only
  HR 1.02 [0.79, 1.32]
  1 study · 161 participants
  Low